Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone.
about
Pharmacokinetic and pharmacodynamic profile of bendamustine and its metabolitesBendamustine for the treatment of multiple myeloma in first-line and relapsed-refractory settings: a review of clinical trial data.Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma.The safety of bendamustine in patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma and concomitant renal impairment: a retrospective electronic medical record database analysis.Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).A Canadian perspective on the safe administration of bendamustine and the prevention and management of adverse events.An old drug with a new future: bendamustine in multiple myeloma.Bendamustine in multiple myeloma.Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.Optimal use of bendamustine in hematologic disorders: Treatment recommendations from an international consensus panel - an updateBendamustine hydrochloride in patients with B-cell malignancies who have comorbidities - is there an optimal dose?Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other.Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma.Bendamustine and prednisone in combination with bortezomib (BPV) in the treatment of patients with relapsed or refractory multiple myeloma and light chain-induced renal failure.United Kingdom Myeloma Forum (UKMF) position statement on the use of bendamustine in myeloma.Dose-intensified bendamustine followed by autologous peripheral blood stem cell support in relapsed and refractory multiple myeloma with impaired bone marrow function.Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
P2860
Q27011795-010A9868-DDCC-4C4B-A118-15B04854A453Q30828090-9BDA86B7-19FB-457B-951B-FCDDE757784FQ33404348-0B7D5704-E57D-4106-8527-7B2FDD7CB704Q33404570-C73CB1B9-248A-43D2-96A5-935912FB5904Q33410064-DFA5EBC9-9163-4F5A-8E2F-63A072AC24DEQ33442039-231CDAE6-873E-428B-A2E9-F4DB319B84E3Q37577645-2E079434-D3B1-42DA-A2E2-FA12FAEDFF58Q38139989-E61211F3-812D-4843-B0BF-CEACEFB7210CQ38530583-464B6889-46FD-49DC-9DEE-204B67A65C2BQ38548134-A9CA0BC9-EF7D-4385-9D05-0301048B9247Q38642648-8ECE5B3E-D70F-4579-A548-6CB206B7B44CQ38700745-F25C5661-6DC8-40E6-BE3B-8D4DB9A97768Q38896793-5918DA85-D539-4459-8EAF-BF4D14377DE0Q39048347-021FA144-4804-4AFA-8DE8-58BD9A568E9FQ40095723-45CFF3E6-0BE6-4C8F-A5A8-815DD9836566Q41970310-D3CF7F27-495A-45BF-9207-C791F39D7AF4Q45892519-8B3EC483-1C32-42BC-8FCB-4A2EB51F552DQ52841629-19A0D87C-20EB-4920-B032-46CAE877426EQ52958098-F2F5B4EC-76B2-41AF-A3E6-65DA9DE6DC12Q53504691-E30B145D-E49D-42CE-9EC9-DBE22D9A89F2
P2860
Successful treatment of patients with newly diagnosed/untreated multiple myeloma and advanced renal failure using bortezomib in combination with bendamustine and prednisone.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Successful treatment of patien ...... h bendamustine and prednisone.
@ast
Successful treatment of patien ...... h bendamustine and prednisone.
@en
type
label
Successful treatment of patien ...... h bendamustine and prednisone.
@ast
Successful treatment of patien ...... h bendamustine and prednisone.
@en
prefLabel
Successful treatment of patien ...... h bendamustine and prednisone.
@ast
Successful treatment of patien ...... h bendamustine and prednisone.
@en
P2093
P2860
P1476
Successful treatment of patien ...... h bendamustine and prednisone.
@en
P2093
Andreas Schwarzer
Anette Bachmann
Cornelia Winkelmann
Dietger Niederwieser
Doreen Hammerschmidt
Ina Wagner
Maik Schwarz
Marc Andrea
Sirak Petros
Thomas Zehrfeld
P2860
P2888
P304
P356
10.1007/S00432-012-1212-4
P577
2012-04-13T00:00:00Z